The Duty to Disclose Adverse Clinical Trial Results
Creator
Liao, S. Matthew
Sheehan, Mark
Clarke, Steve
Bibliographic Citation
American Journal of Bioethics 2009 August; 9(8): 24-32
Abstract
Participants in some clinical trials are at risk of being harmed and sometimes are seriously harmed as a result of not being provided with available, relevant risk information. We argue that this situation is unacceptable and that there is a moral duty to disclose all adverse clinical trial results to participants in clinical trials. This duty is grounded in the human right not to be placed at risk of harm without informed consent. We consider objections to disclosure grounded in considerations of commercial interest, and we argue that these concerns are insufficient to override the moral duty to disclose adverse clinical trial results. However, we also develop a proposal that enables commercial interests to be protected, while promoting the duty to disclose adverse clinical trial results.
Date
2009-08Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
The Duty to Disclose (Even More) Adverse Clinical Trial Results
Hassoun, Nicole (2009-08)